Membrane interaction of calcium channel antagonists modulated by cholesterol. Implications for drug activity

Biochemical Pharmacology

Volumn 45, Issue 11, 1993, Pages 2173-2183

  Mason, R Preston ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDROPYRIDINE DERIVATIVE; AMLODIPINE; CALCIUM ANTAGONIST; CALCIUM CHANNEL; CHOLESTEROL; DILTIAZEM; ISRADIPINE; NIMODIPINE; VERAPAMIL;

ATHEROSCLEROSIS; CELL MEMBRANE; DRUG ACTIVITY; DRUG BINDING; DRUG BIOAVAILABILITY; DRUG MECHANISM; LIPID BILAYER; MEMBRANE COMPONENT; MEMBRANE MODEL; MEMBRANE STRUCTURE; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; SHORT SURVEY;

ANIMAL; BIOLOGICAL AVAILABILITY; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CARDIOVASCULAR SYSTEM; CELL MEMBRANE; CHOLESTEROL; DIHYDROPYRIDINES; HUMAN; LIPID BILAYERS; MODELS, MOLECULAR; PHOSPHATIDYLCHOLINES; RECEPTORS, DRUG; SUPPORT, NON-U.S. GOV'T;

EID: 0027193666     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(93)90186-Z     Document Type: Note

References (44)

1. Local anesthetics: Hydrophilic and hydrophobic pathways for the drug-receptor reaction
2. What is the molecular nature of general anesthetic target sites?
3. Kinetics of binding of membrane-active drugs to receptor sites. Diffusion-limited rates for a membrane bilayer approach of 1,4-dihydropyridine calcium channel antagonists to their active site
4. 3H]nimodipine
5. Induction of calcium currents by the expression of the α-subunit of the dihydropyridine receptor from skeletal muscle
6. Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel
7. Primary structure of the receptor for calcium channel blockers from skeletal muscle
8. The 165-kDa peptide of the purified skeletal muscle dihydropyridine receptor contains the known regulatory sites of the calcium channel
9. 2+ channel inhibitors d-cis-diltiazem, (±)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes
10. Identification of a novel 1,4-dihydropyridine and phenylalkylamine-binding polypeptide in calcium channel preparations
11. Identification and characterization of the dihydro-pyridine-binding subunit of the skeletal muscle dihydropyridine receptor
12. Photoaffinity labelling and phosphorylation of a 165 kilodalton peptide associated with dihydropyridine and phenylalkylamine sensitive calcium channels
13. Subunit structure of dihydropyridinesensitive calcium channels from skeletal muscle
14. Rates of membrane-associated reactions: Reduction in dimensionality revisited
15. Structure-function studies of canine cardiac sarcolemmal membranes. I. Estimation of receptor site densities
16. Structural analysis of drug molecules in biological membranes
17. Interaction of 1,4-dihydropyridine calcium channel antagonists with biological membranes: Lipid bilayer partitioning could occur before drug binding to receptors
18. A comparison of bilayer location and binding for the charged 1,4-dihydropyridine calcium channel antagonist amlodipine with uncharged drugs of this class in cardiac and model membranes
19. 2+ channel blockers to the membrane lipid bilayer
20. Reevaluating equilibrium and kinetic binding parameters for lipophilic drugs based on a structural model for drug interaction with biological membranes
21. Diffusion of dihydropyridine calcium channel antagonists in cardiac sarcolemmal lipid multibilayers
22. Diffusional dynamics of an active rhodamine-labeled 1,4-dihydropyridine in sarcolemmal lipid multibilayers
23. Pharmacological profile of skeletal muscle calcium channels in planar lipid bilayers
24. Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: Evidence for voltage modulation of vascular dihydropyridine receptors
25. Influence of pH on calcium channel block by amlodipine, a charged dihydropyridine compound: Implications for location of the dihydropyridine receptor
26. Excess membrane cholesterol alters calcium movements, cytosolic calcium levels and membrane fluidity in arterial smooth muscle cells
27. Mechanisms and consequences of cellular cholesterol exchange and transfer
28. Stimulation of sodium-calcium exchange by cholesterol incorporation into isolated cardiac sarcolemmal vesicles
29. Structural, compositional and functional alterations of arterial smooth muscle plasma membranes in atherosclerosis
30. Decreased plasma membrane fluidity in the development of atherosclerosis in cholesterol-fed rabbits
31. A structural model for the cholesterol-phosphatidylcholine complexes in bilayer membranes
32. A deuterium nuclear magnetic resonance study of the condensing effect of cholesterol on egg phophatidylcholine bilayer membranes. I. Perdeuterated fatty acid probes
33. Structural analysis of hydrated egg lecithin and cholesterol bilayers
34. The effect of cholesterol on the structure of phosphatidycholine bilayers
35. Structure of aqueous mixtures of lecithin and cholesterol
36. Cholesterol and cell membranes
37. Dietary cholesterol influences cardiac β-adrenergic receptor adenylate cyclase activity in the marmoset monkey by changes in membrane cholesterol status
38. Cholesterolinduced changes in arterial sensitivity to adrenergic stimulation
39. Alterations in membrane phospholipid bilayer composition with age in Fisher 344 rat
40. Vascular responsiveness and eicosenoid production in diabetic rats
41. + and lipid profiles in canine arterial wall with chronic cigarette smoking
42. Influence of cholesterol on equilibrium and dynamic bilayer structure of unsaturated acyl chain phosphatidylcholine vesicles as determined from higher order analysis of fluorescence anisotropy decay
43. Atherogenic activity of excess membrane cholesterol in arterial smooth muscle and endothelial cells
44. Amlodipine exerts a potent antimigrational effect on aortic smooth muscle cells in culture